CD8A and neoplasm: This improvement occurred mainly through reducing the heterogeneous cells in the TME and increasing the infiltration of the CD8+ T cells [25], as well as inhibiting tumor proliferation by activating the C6 glioma immune microenvironment via inducing the transformation of the M2 TAMs into M1 in TME [28] (Fig. 11).